Idioma:

Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh

Qadri, Firdausi ; Wierzba, Thomas F ; Ali, Mohammad ; Chowdhury, Fahima ; Khan, Ashraful I ; Saha, Amit ; Khan, Iqbal A ; Asaduzzaman, Muhammad ; Akter, Afroza ; Khan, Arifuzzaman ; Begum, Yasmin A ; Bhuiyan, Taufiqur R ; Khanam, Farhana ; Chowdhury, Mohiul I ; Islam, Taufiqul ; Chowdhury, Atique I ; Rahman, Anisur ; Siddique, Shah A ; You, Young A ; Kim, Deok R ; Siddik, Ashraf U ; Saha, Nirod C ; Kabir, Alamgir ; Cravioto, Alejandro ; Desai, Sachin N ; Singh, Ajit P ; Clemens, John D

The New England journal of medicine, 2016-05, Vol.374 (18), p.1723-1732 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por

Enviar para

Título:
Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh
Autor: Qadri, Firdausi ; Wierzba, Thomas F ; Ali, Mohammad ; Chowdhury, Fahima ; Khan, Ashraful I ; Saha, Amit ; Khan, Iqbal A ; Asaduzzaman, Muhammad ; Akter, Afroza ; Khan, Arifuzzaman ; Begum, Yasmin A ; Bhuiyan, Taufiqur R ; Khanam, Farhana ; Chowdhury, Mohiul I ; Islam, Taufiqul ; Chowdhury, Atique I ; Rahman, Anisur ; Siddique, Shah A ; You, Young A ; Kim, Deok R ; Siddik, Ashraf U ; Saha, Nirod C ; Kabir, Alamgir ; Cravioto, Alejandro ; Desai, Sachin N ; Singh, Ajit P ; Clemens, John D
Assuntos: Administration, Oral ; Adolescent ; Adult ; Age Factors ; Bangladesh - epidemiology ; Child ; Child, Preschool ; Children ; Cholera ; Cholera - epidemiology ; Cholera - prevention & control ; Cholera Vaccines - administration & dosage ; Cholera Vaccines - immunology ; Dehydration ; Double-Blind Method ; Drug dosages ; Endemic Diseases - prevention & control ; Female ; Humans ; Immunization ; Infant ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Vaccines ; Vaccines, Inactivated - immunology ; Young Adult
É parte de: The New England journal of medicine, 2016-05, Vol.374 (18), p.1723-1732
Notas: ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
Descrição: Development of an easily deployable cholera vaccine for both endemic and epidemic disease is a high priority. In this report from Bangladesh, a single dose of an inactivated oral vaccine is assessed in a setting where cholera is endemic. Cholera remains a serious global health problem despite advances in the understanding of its pathogenesis and treatment 1 , 2 and despite the placement of improved water quality and sanitation at the forefront of global development priorities. 3 Killed oral vaccines against cholera have been under active development since the 1970s. In 2009, a public–private partnership in India developed and licensed a new killed whole-cell-only oral cholera vaccine (Shanchol, Shantha Biotechnics), which was modified from an earlier oral cholera vaccine produced in Vietnam and which is currently priced affordably for the public sector, at $1.85 per dose. In a trial conducted in Kolkata, . . .
Editor: United States: Massachusetts Medical Society
Idioma: Inglês;Norueguês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Resultado 1 Avançar Ir para próxima página

Realização: Logos de Redes Sociais:

Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh

United States: Massachusetts Medical Society

Buscando em bases de dados remotas. Favor aguardar.